• covid 19
    1755
    0

     There is no increased risk of blood clotting post vaccination with Covaxin and Covishield so far, ruled top government committee. The top committee came to the finding post analyzing more than 400 adverse reactions encountered during ongoing vaccination drive in India.  Dr NK Arora, executive director of the INCLEN Trust and an advisor to the ...
  • Bharat Biotech cautions people
    1875
    0

    Individuals who are on medication that affects their immune system are advised not to take Covaxin, the developer Bharat Biotech cautioned on Monday via a factsheet. The company strongly urged people to reveal to their immunization officers about any serious health-related conditions or allergies before getting the jab.  Bharat Biotech stated that people who are ...
  • India's COVID-19 vaccination drive
    2278
    0

    With 1 million COVID-19 shots in just 6 days, India’s vaccination drive becomes the world’s fastest The Indian government has vaccinated nearly 16 lakh people against COVID-19 since the launch of its mass inoculation drive on January 16. According to the Health Ministry, authorities have administered approximately 10 lakh vaccine shots in just six days, ...
  • Doctor injecting Covid19 Vaccine
    2080
    1

    After India has made a mark in marketing the first experimental preventive Covid-19 drug, it is on its way to develop its own indigenous vaccine. After the Central Drugs Standard Control Organisation has allowed Bharat Boitech India (BBIL) to start human trials, Covaxin might become the first Indian vaccine candidate to prevent the spread of ...
  • Indian Vaccine
    1715
    0

    Indian Vaccine: The Covaxin vaccine is getting embroiled in domestic skirmish even before its delivery schedules have been put into place. The bone of contention is the fact that the vaccine has been granted emergency approval even before the human trials were completed.  There is communal disharmony over the contents of the vaccine. The main ...
  • Covaxin
    1804
    0

    As per the official reports, the first vaccine being developed in India–Covaxin will be launched by the second quarter next year. The company official confirmed that once it is approved the vaccine will be made available to the public. “If we get all the approvals after establishing strong experimental evidence and data, and efficacy and ...